Ethirajan Pavithra, Lakshmanan Archana
Department of Histopathology, Apollo Cancer Centre, Chennai, Tamil Nadu, India.
J Orthop Case Rep. 2025 Aug;15(8):107-110. doi: 10.13107/jocr.2025.v15.i08.5902.
Adamantinoma is a primary low-grade malignant bone tumor. It is most common in tibia with slight predilection in males. Dedifferentiated adamantinoma is an aggressive variant with worse prognosis.
Patient is a 70-year-old female who presented with leg pain. Imaging showed a lytic lesion in the metaphyseo diaphyseal region. Curettings were done and were reported as adamantinoma. Two years later, the patient presented with a recurrent lesion at the same site. Histopathology showed a neoplasm with focal classical adamantinoma and many areas with aggressive morphology including sarcomatoid differentiation. The neoplastic cells in high-grade areas were positive for vimentin with variable loss of cytokeratin. Proliferative index as determined by Ki67 was 20-25% in these areas. With these given immuno-morphological findings, a diagnosis of dedifferentiated adamantinoma was rendered.
Dedifferentiated adamantinoma is an unusual and aggressive variant of adamantinoma. This case highlights the awareness of such a rare entity, thereby preventing misdiagnosis and improper treatment.
骨化性纤维瘤是一种原发性低度恶性骨肿瘤。最常见于胫骨,男性略多。去分化骨化性纤维瘤是一种侵袭性变体,预后较差。
患者为一名70岁女性,因腿痛就诊。影像学检查显示干骺端骨干区域有溶骨性病变。进行了刮除术,病理报告为骨化性纤维瘤。两年后,患者在同一部位出现复发病变。组织病理学显示肿瘤具有局灶性经典骨化性纤维瘤,许多区域具有侵袭性形态,包括肉瘤样分化。高级别区域的肿瘤细胞波形蛋白阳性,细胞角蛋白可变丢失。这些区域中由Ki67确定的增殖指数为20%-25%。根据这些免疫形态学结果,诊断为去分化骨化性纤维瘤。
去分化骨化性纤维瘤是骨化性纤维瘤的一种罕见且侵袭性变体。该病例强调了对这种罕见实体的认识,从而防止误诊和不恰当的治疗。